Target Trial Emulation for Transparent and Robust Estimation of Treatment Effects for Health Technology Assessment Using Real-World Data: Opportunities and Challenges Manuel GomesNick LatimerRichard Grieve Current Opinion 25 March 2022 Pages: 577 - 586
Disease-Related Costs Published in The Middle East and North Africa Region: Systematic Review and Analysis of Transferability Zsombor ZrubkaMárta PéntekLászló Gulácsi Systematic Review Open access 17 May 2022 Pages: 587 - 599
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations Don HusereauMichael DrummondSophie Staniszewska Original Research Article Open access 11 January 2022 Pages: 601 - 609
A Comparison of Methods for Identifying Informal Carers: Self-Declaration Versus a Time Diary Sean UrwinYiu-Shing LauMatt Sutton Original Research Article Open access 08 April 2022 Pages: 611 - 621
Modeling the Ex Ante Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung Cancer Woojung LeeWilliam B. WongMeng Li Original Research Article Open access 09 May 2022 Pages: 623 - 631
Evaluating the Individual Healthcare Costs and Burden of Disease Associated with RSV Across Age Groups Ellen RaffertyMike Pauldenthe Canadian Immunization Research Network (CIRN) investigators Original Research Article Open access 13 May 2022 Pages: 633 - 645